Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1526 of 5804
-
Can a therapy app keep kids safe from gun violence?
Prevention CompletedThe present study is evaluating the efficacy of a behavioral intervention to reduce risky firearm carriage among a high risk sample of youth reporting recent firearm carriage and ownership of a smartphone.
Phase: NA • Sponsor: University of Michigan • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
New dual-targeting CAR t therapy tested for hard-to-treat lymphoma
Disease control TerminatedThis non-randomized, open label, multi-site, first-in-human, Phase 1/2 study CRC-403 will evaluate the safety and efficacy of bbT369 in subjects with relapsed and/or refractory B cell non-Hodgkin's lymphoma (NHL). A long-term follow-up (LTF-01 \[NCT06798298\]) is planned, in whi…
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Can problem-solving therapy save older veterans from suicide?
Symptom relief TerminatedSuicide is a national crisis, especially among older Veterans for whom evidence-based suicide prevention efforts are lacking. This proposal responds to the national priority to develop and improve interventions for suicide prevention, with a focus on at-risk older Veterans. The r…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Could a Blood-Derived injection ease jaw pain without surgery?
Disease control ENROLLING_BY_INVITATIONThe aim of the study is to evaluate the effectiveness of intra-articular platelet-rich fibrin (iPRF) injections in the management of moderate and mild cases of degeneration of the temporomandibular joints. This randomized, two-arm controlled trial will involve 42 adult patients d…
Phase: PHASE2, PHASE3 • Sponsor: Wroclaw Medical University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Spinal cord injury patients may regain hand function with implanted device
Disease control Recruiting nowThe overall objective of this trial is to characterize the safety and effectiveness of the Networked Neuroprosthesis Device - Upper Extremity (NP-UE) in individuals living with cervical SCI.
Phase: NA • Sponsor: MetroHealth Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Military suicide study tracks Real-Time coping strategies
Knowledge-focused Recruiting nowCrisis Response Planning is an efficacious, one-session intervention that increases positive affect, decreases negative affect and psychiatric hospitalizations, and reduces suicide attempts by 76% among Servicemembers. Crisis Response Planning is hypothesized to reduce suicidalit…
Phase: NA • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedA Phase Ib/II Clinical Study Evaluating HMPL-453 Tartrate as Monotherapy and in Combination with Chemotherapy or Toripalimab in Advanced Solid Tumors
Phase: PHASE1, PHASE2 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New PET tracer aims to spot Alzheimer's tau tangles
Diagnosis CompletedThe overall objective of this study is to compare the overall pattern of \[18F\]APN-1607 uptake in subjects with MCI, subjects with AD dementia, and healthy subjects.
Phase: PHASE3 • Sponsor: APRINOIA Therapeutics • Aim: Diagnosis
Last updated Jun 26, 2026 14:53 UTC
-
Higher dose of spinraza tested in SMA patients who already tried risdiplam
Disease control OngoingIn this study, researchers will learn more about the use of a higher dose of nusinersen (BIIB058) in participants with spinal muscular atrophy (SMA). This study will focus on teenagers and adults who are unable to walk on their own and who have previously taken another drug for S…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a simple dose change make a tough cancer drug easier to take?
Disease control Recruiting nowThis is a multi-site, three-cohort phase II trial of cabozantinib for IMDC all-risk frontline metastatic renal cell carcinoma (mRCC) patients OR any line mRCC patients who have not previously been treated with cabozantinib, and patients with pancreatic or extra-pancreatic neuroen…
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a single cell treatment free liver transplant patients from lifelong drugs?
Disease control OngoingThe purpose of this study is to evaluate the safety and tolerability of QEL-001 in the prevention of liver transplant rejection following immunosuppression withdrawal. QEL-001 is a product made from a patients own cells, which are genetically modified and designed to help the tra…
Phase: PHASE1, PHASE2 • Sponsor: Quell Therapeutics Limited • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Zapping the brain to heal after concussion: new trial tests two non-invasive techniques
Disease control Recruiting nowThe CONNECT-TBI Trial aims to develop safe, effective treatments for complex mTBI that improve cognitive functioning. Based on the compelling preliminary data generated by our study team, the objective of this study is to conduct a randomized, double-blinded, sham-controlled Phas…
Phase: NA • Sponsor: University of New Mexico • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can adding radiation to osimertinib keep lung cancer in check?
Disease control OngoingStudy Objectives are: To assess the safety of osimertinib treatment continuation during irradiation therapy for palliation or oligoprogressive disease by assessment of grade 3-5 AEs during and after concomitant osimertinib and irradiation of tumor sites. To assess the efficacy …
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Personalized diet and exercise program aims to stop childhood obesity before it starts
Prevention OngoingObesity could be avoided but once declared it become a chronic disease with numerous health complications, including cardiovascular and metabolic diseases, cancers, and finally a loss of life expectancy. Considering that after the age of 6 years old, half of the obese children wi…
Sponsor: University Hospital, Lille • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Potassium binder lets heart patients get full drug benefits
Disease control CompletedBackground: CKD in patients with heart failure (HF) is common and associated with poor prognosis. Despite evidence of benefit with Renin-Angiotensin-Aldosterone-System inhibitor (RAASi) agents, they are avoided due to fear of hyperkalaemia. New potassium binders, e.g. Sodium Zirc…
Phase: PHASE3 • Sponsor: St George's, University of London • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Weekly pill could tame painful birthmarks with fewer side effects
Disease control Recruiting nowIn current practice, options for venous and lymphatic malformations remain limited. Recently an oral medication, sirolimus, has been found to benefit patients when taken once or twice a day for several months. Unfortunately there are many side effects associated with this medicat…
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Simple cuff trick may shield hearts from chemo damage
Disease control Recruiting nowMultinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic PreConditioning (RIPC) in Lymphoma patients receiving anthracyclines.
Phase: NA • Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III • Aim: Disease control
Last updated Jun 26, 2026 18:39 UTC
-
New pill aims to keep AML in remission for older japanese patients
Disease control OngoingThe purpose of this study is to assess the efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in a cohort of Japanese participants ≥ 55 years of age with Acute Myeloid Leukemia (AML) and in complete remission/compl…
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could a common Anti-Inflammatory pill boost biologic therapy for ulcerative colitis?
Disease control CompletedEndocopic remission rates of moderate to severe ulcerative colitis are low. Biologics including Vedolizumab, infliximab, and adalimumab are effective in induction and maintainence of ulcerative colitis. The role of 5-ASA in promoting a higher rate of endocsopic remission is uncle…
Phase: PHASE4 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New combo therapy aims to fight Hard-to-Treat GIST tumors
Disease control Recruiting nowThis trial is a prospective, randomized (1:1 ratio), multicenter, comparative and phase II study, conducted in patients with unresectable advanced gastrointestinal stromal tumors (GIST) after failure of imatinib (disease progression),sunitinib and regorafenib (either disease prog…
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC